Recursion Pharmaceuticals Inc Cl A
(RXRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 474,456 | 551,192 | 456,736 | 455,776 | 509,412 |
| Marketable Securities | N/A | N/A | N/A | 61,561 | 83,214 |
| Receivables | 2,057 | 2,753 | 11,635 | 11,680 | 11,397 |
| Other current assets | 15,612 | 15,869 | 13,247 | 16,979 | 15,432 |
| TOTAL | $492,125 | $569,814 | $481,618 | $545,996 | $619,455 |
| Non-Current Assets | |||||
| PPE Net | 90,004 | 88,192 | 85,777 | 81,508 | 70,704 |
| Intangibles | 2,119 | 2,107 | 2,258 | 2,034 | 2,110 |
| Other Non-Current Assets | 43,118 | 41,175 | 41,880 | 42,977 | 42,050 |
| TOTAL | $135,241 | $131,474 | $129,915 | $126,519 | $114,864 |
| Total Assets | $627,366 | $701,288 | $611,533 | $672,515 | $734,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,247 | 4,586 | 3,890 | 3,176 | 4,162 |
| Accrued Expenses | 25,041 | 32,904 | 26,757 | 24,361 | 23,118 |
| Other current liabilities | 57,761 | 56,726 | 46,753 | 63,781 | 54,247 |
| TOTAL | $92,150 | $100,265 | $83,036 | $96,653 | $85,705 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,179 | 536 | 561 | 586 | 610 |
| Other Non-Current Liabilities | 103,862 | 114,681 | 139,902 | 137,697 | 154,438 |
| TOTAL | $105,041 | $115,217 | $140,463 | $138,283 | $155,048 |
| Total Liabilities | $197,191 | $215,482 | $223,499 | $234,936 | $240,753 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 192,359 | 191,233 | 189,556 | 173,077 | 172,007 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -704,883 | -639,556 | -582,064 | -521,619 | -456,059 |
| Other shareholders' equity | 0 | 0 | 0 | -197 | -309 |
| TOTAL | $430,175 | $485,806 | $388,034 | $437,579 | $493,566 |
| Total Liabilities And Equity | $627,366 | $701,288 | $611,533 | $672,515 | $734,319 |